ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $10,000 | +11.1% | 399 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $9,000 | -80.9% | 399 | -75.0% | 0.00% | -71.4% |
| Q1 2016 | $47,000 | -11.3% | 1,599 | 0.0% | 0.01% | -30.0% |
| Q4 2015 | $53,000 | -13.1% | 1,599 | 0.0% | 0.01% | -9.1% |
| Q3 2015 | $61,000 | -47.9% | 1,599 | -38.5% | 0.01% | -45.0% |
| Q2 2015 | $117,000 | +875.0% | 2,599 | +551.4% | 0.02% | +900.0% |
| Q1 2015 | $12,000 | – | 399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |